Sana Biotechnology Inc (SANA)
10.04
+0.04
(+0.40%)
USD |
NASDAQ |
May 07, 16:00
10.04
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Net Income (TTM): -283.26M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -283.26M |
| September 30, 2023 | -275.58M |
| June 30, 2023 | -361.68M |
| March 31, 2023 | -320.15M |
| December 31, 2022 | -269.48M |
| September 30, 2022 | -299.76M |
| June 30, 2022 | -297.91M |
| Date | Value |
|---|---|
| March 31, 2022 | -206.76M |
| December 31, 2021 | -355.93M |
| September 30, 2021 | -358.37M |
| June 30, 2021 | -326.56M |
| March 31, 2021 | -433.05M |
| December 31, 2020 | -285.30M |
| September 30, 2020 | -215.18M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-433.05M
Minimum
Mar 2021
-206.76M
Maximum
Mar 2022
-306.35M
Average
-298.84M
Median
Net Income (TTM) Benchmarks
| Rocket Pharmaceuticals Inc | -245.60M |
| Solid Biosciences Inc | -96.02M |
| Dyne Therapeutics Inc | -257.40M |
| Taysha Gene Therapies Inc | -111.57M |
| Tenaya Therapeutics Inc | -124.08M |